ArticleCancer science2014

Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification.

Won-Jun Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.